| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 85.628 | 162.768 | 224.772 | 249.273 | 294.804 | 16.813 | 0 | 0 | 5.954 | 0 |
| Total Income - EUR | 85.628 | 162.768 | 224.772 | 254.691 | 294.804 | 16.813 | 0 | 125.384 | 7.652 | 77.398 |
| Total Expenses - EUR | 79.286 | 177.438 | 206.956 | 244.963 | 179.811 | 64.842 | 21.834 | 49.823 | 16.789 | 19.736 |
| Gross Profit/Loss - EUR | 6.342 | -14.670 | 17.815 | 9.728 | 114.993 | -48.029 | -21.834 | 75.561 | -9.137 | 57.661 |
| Net Profit/Loss - EUR | 5.323 | -15.919 | 13.914 | 7.160 | 112.042 | -48.199 | -21.834 | 71.799 | -19.252 | 55.339 |
| Employees | 3 | 5 | 5 | 6 | 4 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Almatera Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 20.643 | 14.165 | 34.485 | 20.499 | 12.601 | 5.223 | 61.002 | 291.449 | 270.405 |
| Current Assets | 23.339 | 32.220 | 39.862 | 73.509 | 161.257 | 37.002 | 35.813 | 159.347 | 8.980 | 15.977 |
| Inventories | 9.908 | 26.451 | 32.884 | 22.086 | 19.287 | 6.096 | 6.779 | 5.924 | -1.484 | 0 |
| Receivables | 3.252 | 5.695 | 6.821 | 9.213 | -8.482 | 17.637 | 19.479 | 17.231 | 8.695 | 14.217 |
| Cash | 10.180 | 75 | 157 | 42.210 | 150.452 | 13.268 | 9.555 | 136.191 | 1.769 | 1.759 |
| Shareholders Funds | 3.044 | -12.906 | 1.226 | 8.364 | 120.243 | 69.765 | 46.384 | 118.328 | 98.716 | 153.504 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.295 | 65.770 | 52.801 | 99.629 | 61.513 | 84.893 | 97.379 | 245.622 | 201.713 | 132.878 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Almatera Pharm Srl